HIGHLIGHTS
- who: Sharon Wolters MSc from the University of Groningen have published the paper: Differences in Evidentiary Requirements Between European Medicines Agency and European Health Technology Assessment of Oncology Drugs-Can Alignment Be Enhanced?, in the Journal: (JOURNAL)
- what: This study showed that EMA had a higher degree of acceptability of evidence than HTA bodies, indicating that HTA bodies have different or more stringent evidentiary requirements. This article provides an initial overview of the evidence gaps between EMA and European HTA bodies.
- how: A comparative analysis was conducted in which the evidentiary requirements of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.